. Targeting alpha-synuclein or tau for treating neurodegenerative movement disorders. Rev Neurol (Paris). 2022 May;178(5):460-471. Epub 2022 May 11 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.